Related Experiment Video

Updated: Nov 20, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

Clinical Outcomes of Critically III Patients with COVID-19 by Race

Fahad Marmarchi1, Michael Liu1, Srikant Rangaraju1

  • 1Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.

Journal of Racial and Ethnic Health Disparities
|January 20, 2021
PubMed

Insights

African Americans with COVID-19 had higher rates of comorbidities like hypertension and diabetes. Despite needing more renal replacement therapy, their intensive care unit outcomes and mortality were similar to other races.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Public health

Background:

  • COVID-19 disproportionately affects African Americans.
  • Understanding racial disparities in critical care for COVID-19 is essential.
  • Comorbidities and clinical outcomes require examination across racial groups.

Purpose of the Study:

  • To investigate comorbidities and clinical outcomes by race among intensive care unit (ICU) patients with COVID-19.
  • To compare the severity of illness and treatment needs between African American and other racial groups admitted to the ICU.

Main Methods:

  • A case series of critically ill COVID-19 patients admitted to an academic healthcare system in Atlanta, Georgia.
  • Inclusion criteria: critically ill hospitalized patients between March 6, 2020, and May 5, 2020.
  • Outcomes analyzed: mechanical ventilation, renal replacement therapy, and mortality, stratified by race.

Main Results:

  • The study included 288 patients; 73% were African American.
  • African Americans exhibited higher rates of hypertension, diabetes, and higher mean BMI.
  • Despite increased need for renal replacement therapy in African Americans, intubation rates, ICU length of stay, and overall mortality were similar across racial groups.

Conclusions:

  • Critically ill COVID-19 patients in this cohort were racially diverse.
  • African Americans presented with more comorbidities but experienced similar mortality rates compared to other races.
  • Findings highlight the complex interplay of race, comorbidities, and critical care outcomes in COVID-19.
Abstract

Keywords:
African AmericanCOVID-19MortalityOutcomesRace

More Related Videos

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.0K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.3K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
603
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
518
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
747
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
568
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
96
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
297